Schunkert, Heribert

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 8.

Journal Article

Gragnano, Felice; Cao, Davide; Pirondini, Leah; Franzone, Anna; Kim, Hyo-Soo; von Scheidt, Moritz; Pettersen, Alf-Åge R; Zhao, Qiang; Woodward, Mark; Chiarito, Mauro; McFadden, Eugene P; Park, Kyung Woo; Kastrati, Adnan; Seljeflot, Ingebjørg; Zhu, Yunpeng; Windecker, Stephan; Kang, Jeehoon; Schunkert, Heribert; Arnesen, Harald; Bhatt, Deepak L; ... (2023). P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events. Journal of the American College of Cardiology, 82(2), pp. 89-105. Elsevier 10.1016/j.jacc.2023.04.051

Gehlen, Jan; Stundl, Anja; Debiec, Radoslaw; Fontana, Federica; Krane, Markus; Sharipova, Dinara; Nelson, Christopher P; Al-Kassou, Baravan; Giel, Ann-Sophie; Sinning, Jan-Malte; Bruenger, Christopher M H; Zelck, Carolin F; Koebbe, Laura L; Braund, Peter S; Webb, Thomas R; Hetherington, Simon; Ensminger, Stephan; Fujita, Buntaro; Mohamed, Salah A; Shrestha, Malakh; ... (2023). Elucidation of the genetic causes of bicuspid aortic valve disease. Cardiovascular research, 119(3), pp. 857-866. Oxford University Press 10.1093/cvr/cvac099

Sandner, Sigrid; Kastrati, Adnan; Niessner, Alexander; Böning, Andreas; Zeymer, Uwe; Conradi, Lenard; Danner, Bernhard; Zimpfer, Daniel; Färber, Gloria; Manville, Emely; Schunkert, Heribert; von Scheidt, Moritz (2023). Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial. International journal of cardiology, 370, pp. 129-135. Elsevier 10.1016/j.ijcard.2022.10.166

Clark, David W; Okada, Yukinori; Moore, Kristjan H S; Mason, Dan; Pirastu, Nicola; Gandin, Ilaria; Mattsson, Hannele; Barnes, Catriona L K; Lin, Kuang; Zhao, Jing Hua; Deelen, Patrick; Rohde, Rebecca; Schurmann, Claudia; Guo, Xiuqing; Giulianini, Franco; Zhang, Weihua; Medina-Gomez, Carolina; Karlsson, Robert; Bao, Yanchun; Bartz, Traci M; ... (2019). Associations of autozygosity with a broad range of human phenotypes. Nature communications, 10(1), p. 4957. Nature Publishing Group 10.1038/s41467-019-12283-6

Alushi, Brunilda; Lauten, Alexander; Cassese, Salvatore; Colleran, Roisin; Schüpke, Stefanie; Rai, Himanshu; Schunkert, Heribert; Meier, Bernhard; Landmesser, Ulf; Kastrati, Adnan (2018). Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials. Clinical research in cardiology, 107(9), pp. 788-798. Springer-Verlag 10.1007/s00392-018-1246-y

Cassese, Salvatore; Byrne, Robert A; Jüni, Peter; Wykrzykowska, Joanna J; Puricel, Serban; Ndrepepa, Gjin; Schunkert, Heribert; Fusaro, Massimiliano; Cook, Stephane; Kimura, Takeshi; Henriques, Jose P S; Serruys, Patrick W; Windecker, Stephan; Kastrati, Adnan (2018). Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention, 13(13), pp. 1565-1573. Europa Digital & Publishing 10.4244/EIJ-D-17-00492

Xhepa, Erion; Tada, Tomohisa; Kufner, Sebastian; Ndrepepa, Gjin; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralf; Cassese, Salvatore; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl L; Mehilli, Julinda; Kastrati, Adnan (2017). Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. Catheterization and cardiovascular interventions, 89(1), pp. 1-10. Wiley-Blackwell 10.1002/ccd.26645

Cassese, Salvatore; Kufner, Sebastian; Xhepa, Erion; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralph; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl-Ludwig; Mehilli, Julinda; Kastrati, Adnan (2016). Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clinical research in cardiology, 105(7), pp. 575-584. Springer-Medizin-Verlag 10.1007/s00392-015-0953-x

This list was generated on Wed Apr 24 16:05:53 2024 CEST.
Provide Feedback